NCT07561125

Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and Below

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-04-23Est. Completion: 2027-09

Enrollment target: 29 participants

Locations

Contact

Bronchopulmonary Dysplasia (BPD)

The goal of this clinical trial is to learn if budesonide works to prevent bronchopulmonary dysplasia in newborn less th…

Jakarta, IndonesiaCompleted Apr 24, 2025

Bronchopulmonary Dysplasia

Bronchopulmonary dysplasia (BPD) is one of the most common and severe complications of extreme prematurity, affecting ap…

Modena, ItalyEst. completion Feb 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.